Biotech Eiger Can Take Sentynl's Improved Drug Bid In Ch. 11

By Alex Wittenberg · April 3, 2024, 8:00 PM EDT

Eiger BioPharmaceuticals Inc. received approval Wednesday to select a $30 million base offer for its Zokinvy drug and use cash collateral after a Texas bankruptcy judge dismissed objections to the relief,...

To view the full article, register now.

Bankruptcy Scorecard

Summary

Eiger BioPharmaceuticals Inc. filed for Chapter 11 protection in Texas bankruptcy court with $53.1 million of debt and plans to sell its assets during the case.

Case Number

8:24-bk-80040

Judge

Stacey Jernigan

Venue

U.S. Bankruptcy Court for the Northern District of Texas

Capital Structure

Total Liabilities:

$53.1 million

View Full Scorecard

Case Information

Case Title

Eiger BioPharmaceuticals, Inc.

Case Number

8:24-bk-80040

Court

Texas Northern

Nature of Suit

Date Filed

April 01, 2024